Literature DB >> 21896972

Breath analysis: clinical research to the end-user market.

T Smith1.   

Abstract

Breath research is now well established and is solving some of the applications in the area of identifying volatiles for medical diagnosis. This paper looks at how this research has been taken to an end-user market. It is not intended to be an indepth study of the science but simply to draw attention to the role of the commercial link between the researcher and end-user. This market is not only in research but exists in hospitals, clinics, sports medicine and even homecare. The link between research and the end-user market is a vital one to avoid breath analysis being the tool of researchers only. The ubiquitous use of breath analysis depends upon it. This is a review of some of the success stories in commercializing the important breath analysis research that has been conducted over the last few decades. In order to make breath analysis the new blood test, products that have end-user appeal need to be developed and routes to market established.

Entities:  

Mesh:

Year:  2011        PMID: 21896972     DOI: 10.1088/1752-7155/5/3/032001

Source DB:  PubMed          Journal:  J Breath Res        ISSN: 1752-7155            Impact factor:   3.262


  3 in total

Review 1.  Bacterial volatiles and diagnosis of respiratory infections.

Authors:  James E Graham
Journal:  Adv Appl Microbiol       Date:  2013       Impact factor: 5.086

2.  Assessing the utility of a virtual-reality neuropsychological test battery, 'CONVIRT', in detecting alcohol-induced cognitive impairment.

Authors:  Isabella Amato; Aleshia Nanev; Stefan Piantella; Kira-Elise Wilson; Rowena Bicknell; Rachael Heckenberg; Ben Horan; Paul Maruff; Bradley Wright
Journal:  Behav Res Methods       Date:  2020-09-28

3.  Fuel-cell breathalyser use for field research on alcohol intoxication: an independent psychometric evaluation.

Authors:  Jacob G Sorbello; Grant J Devilly; Corey Allen; Lee R J Hughes; Kathleen Brown
Journal:  PeerJ       Date:  2018-03-14       Impact factor: 2.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.